US Stem Cell Inc (USRM)

[Dragon Lady]

"I hope he does a good job, for us as shareholders "

Well, since he took over as CEO in mid 2010, he's produced about a 95% or greater LOSS for the common shareholders. That's a 4 yr, going on 5 yr "turn around attempt". Most CEO's are typically given about 2, maybe 3 yrs tops to "right the ship", else they get the boot.

So, not sure what one's expectations are as a shareholder? If it's continual losses and lots of common share dilution, then this one might be winner IMO.

Share price around mid 2010 when Tomas took over as CEO was about .50 cents, w/ maybe a spike to two as high as .70 cents. (look at a chart going back to 2010). On his watch, the stock saw it's all time historic low of .0063 (6/10ths of one cent) in Dec of 2013.

There were about 30 million shares of stock outstanding when he took over. Today there's gonna be at least 600 MILLION or so (517 MILLION as of last 10-Q filing, 3 month old data now).

Also, if one does the math, in 2010 the market cap would have been about 30 million shares X .50 cents = approx. $15 MILLION dollars.

Today's market cap as of this AM is at about $10 MILLION. So he's overseen about a 33% loss in the market cap of the company too. Again, not sure what one's expectations are as common shareholder, but the general idea is normally to grow the company and thus grow and increase the market capitalization, not see it decline. Just sorta the way it works in the markets.

Despite all this fantastic performance and diminishing returns to the common shareholder's, the CEO's pay has increased dramatically, most dramatically in 2014, rising to now approx. $1 MILLION in just base pay + Cash bonuses ($525K base salary + $500K cash bonus, see latest SEC 10-Q filing compensation table), not even counting stock options, medical and I'm sure other perks and benefits he receives, paid for by BHRT.

Here's the share dilution numbers from their own SEC filings:

From 10-Q for Q-3 2010, PAGE 1: (a few months after he takes over as CEO)

"As of September 30, 2010 there were 29,366,985 outstanding shares of the registrant’s common stock, par value $0.001 per share."


So there's about 30 MILLION, yes, 30 MILLION shares O/S total then in mid 2010 when he starts as CEO and in full control and a share price North of .50 cents or so.

Share count today, from most recent filed 10-Q, Q-2, 2014, PAGE 1:
"As of August 1, 2014, there were 517,272,472 outstanding shares of the Registrant’s common stock, par value $0.001 per share."

That's about a 517/30 = 17 fold INCREASE in the outstanding shares (and it's still increasing constantly, w authorized shares now increased to 2 BILLION available)